116 related articles for article (PubMed ID: 32341584)
21. [Analysis of risk factors for recurrence after treatment of endometrial uterine cancer].
Zalewski K; Rzepka J; Madry R; Dańska-Bidzińska A; Bidzinski M
Ginekol Pol; 2009 Sep; 80(9):687-93. PubMed ID: 19886243
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
23. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
24. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
Heudel PE; Fervers B; Durand T; Chabaud S; Michallet AS; Gomez F; Rivoire M; Bachelot T; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Chvetzoff G; Pérol D; Blay JY
Int J Clin Oncol; 2021 Oct; 26(10):1793-1804. PubMed ID: 34091824
[TBL] [Abstract][Full Text] [Related]
25. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
26. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
[TBL] [Abstract][Full Text] [Related]
27. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
[TBL] [Abstract][Full Text] [Related]
28. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
29. Second primary cancers in patients with urothelial cancers.
Şahin AF; Altok M; Akdeniz F; Yıldız G; Divrik RT
Investig Clin Urol; 2016 Sep; 57(5):330-5. PubMed ID: 27617314
[TBL] [Abstract][Full Text] [Related]
30. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
[TBL] [Abstract][Full Text] [Related]
31. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
[TBL] [Abstract][Full Text] [Related]
32. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study.
Ruan Z; Zhang Y; Li Z; Jiang J; Luo W; Quan Q; Xu Z; Lei J; Peng R
Clin Exp Med; 2023 Dec; 23(8):5051-5062. PubMed ID: 37555912
[TBL] [Abstract][Full Text] [Related]
34. The association of breast disease and atypical glandular cells on cervical cytology.
Schnatz PF; Pattison K; O'Sullivan DM
Menopause; 2011 Jan; 18(1):67-72. PubMed ID: 20671577
[TBL] [Abstract][Full Text] [Related]
35. Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005.
Arab M; Noghabaei G; Kazemi SN
Asian Pac J Cancer Prev; 2014; 15(6):2461-4. PubMed ID: 24761847
[TBL] [Abstract][Full Text] [Related]
36. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.
Yamagami W; Aoki D
J Obstet Gynaecol Res; 2015 Feb; 41(2):167-77. PubMed ID: 25370711
[TBL] [Abstract][Full Text] [Related]
37. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
38. [Recent trends in multiple primary cancers associated with gynecological malignancy].
Sakaguchi I; Katabuchi H; Okamura H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():607-10. PubMed ID: 15535317
[No Abstract] [Full Text] [Related]
39. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
40. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C
Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
